Monday, October 24, 2011: 7:00 AM
Grand Ballroom AB (Hyatt Regency Chicago)
| Category Reference |
| BEC | Behavioral Economics |
ESP | Applied Health Economics, Services, and Policy Research |
| DEC | Decision Psychology and Shared Decision Making |
MET | Quantitative Methods and Theoretical Developments |
* Candidate for the Lee B. Lusted Student Prize Competition
Poster Board #
2
(ESP)
*
A COST-EFFECTIVENESS ANALYSIS OF OFF-LABEL BIOLOGICS TO TREAT SARCOID POSTERIOR UVEITIS VERSUS STANDARD OF CARE: COMPARING INFLIXIMAB TO METHOTREXATE AND SYSTEMIC STEROIDS
William V. Padula, MS, University of Colorado, Aurora, CO, Taygan Yilmaz, MPH, Dartmouth College, Lebanon, NH and Miguel Cordero-Coma, M.D., Hospital de Leon, Leon, Spain
4
(ESP)
*
DOES TREATMENT OF ASYMPTOMATIC HYPERURICEMIA IMPROVE HEALTH OUTCOMES? A DECISION- ANALYTIC EVALUATION
Roopa Akkineni1, Alexandra Lee2, Katherine L. Miller3, Anna N.A. Tosteson, ScD4, Hyon K. Choi5, Yanyan Zhu5 and Daniel Albert1, (1)Dartmouth Hitchcock Medical Center, Lebanon, NH, (2)Veterans Affairs, White River Junction, VT, (3)Northeastern Ohio Universities College of Medicine, Rootstown, OH, (4)The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, (5)Boston University, Boston, MA
5
(ESP)
*
TO BE SCREENED OR NOT TO BE SCREENED? THE CONSEQUENCES OF PROSTATE-SPECIFIC ANTIGEN SCREENING FOR THE INDIVIDUAL
E.M. Wever, MSc1, G. Draisma, PhD1, Eveline A.M. Heijnsdijk, PhD2 and H. J. de Koning, PhD, MD1, (1)Erasmus Medical Center, Rotterdam, Netherlands, (2)Erasmus MC, Rotterdam, Netherlands
6
(ESP)
*
ULNAR NEUROPATHY AT THE ELBOW: A COST-UTILITY ANALYSIS
Jae W. Song, M.D., M.S., Kevin C. Chung, M.D., M.S. and Lisa A. Prosser, M.S., Ph.D., University of Michigan, Ann Arbor, MI
8
(ESP)
*
USE OF HIGH-SENSITIVE TROPONIN T ASSAY FOR THE EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN CHEST PAIN PATIENTS: AN ECONOMIC EVALUATION
Anil Vaidya, MBBS, MPH1, Johan L. Severens, PhD2, Brenda W.C. Bongaerts, PhD3, Kitty B.J.M. Cleutjens, PhD3, Patty J. Nelemans, MD, PhD4, Leonard Hofstra, MD, PhD5, Marja Van Dieijen-Visser, PhD6 and Erik A.L. Biessen, PhD3, (1)Maastricht University, Maastricht, Netherlands, (2)Erasmus University Rotterdam, Rotterdam, Netherlands, (3)Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, Netherlands, (4)Department of Epidemiology, Maastricht University, Maastricht, Netherlands, (5)Cardiology Centrum, Utrecht, Netherlands, (6)Department of Clinical Chemistry, Maastricht University, Maastricht, Netherlands
9
(ESP)
*
UNIVERSAL NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY: A COST EFFECTIVENESS ANALYSIS
Rachel A. Pilliod, Oregon Health & Science University, Portland, OR, Mika Ohno, University of California, San Francisco, San Francisco, CA, Brian L. Shaffer, MD, Oregon Health and Sciences University, Portland, OR, Maria I. Rodriguez, MD, MPH, Oregon Health and Science University, Portland, OR and Aaron B. Caughey, MD, MPP, MPH, PhD, Oregon Health & Sciences University, Portland, OR
10
(ESP)
*
CAROTID ENDARTERECTOMY VERSUS STENTING: A DECISION ANALYSIS
Daniel Yavin, MD1, Starr Tze, PENg2, John H. Wong, MD, MSc1 and Garnette R. Sutherland, MD1, (1)University of Calgary, Calgary, AB, Canada, (2)Curtin University, Calgary, AB, Canada
11
(ESP)
*
CREATING A VOCABULARY FRAMEWORK FOR PTSD: TOWARD A BETTER UNDERSTANDING OF SYMPTOMATOLOGY, TREATMENT, RESILIENCY, AND SUICIDALITY
Maryan Zirkle, MD, MA1, Dallas Swanson, BS1, Susan Severance, MPH1, Stephen L. Luther, PhD, MBA2 and David H. Hickam, MD, MPH1, (1)Portland VA Medical Center, Portland, OR, (2)James A. Haley VA Hospital, Tampa, FL
12
(ESP)
*
TWO-YEAR DIRECT AND INDIRECT COSTS FOR PATIENTS WITH INFLAMMATORY RHEUMATIC JOINT DISEASES: DATA FROM REAL LIFE FOLLOW-UP OF PATIENTS IN THE NOR-DMARD REGISTRY
Maria K. Kvamme, MSc1, Elisabeth Lie, MD, Research, fellow2, Tore K. Kvien, MD, PhD, Professor2 and Ivar Sønbø Kristiansen, MD, PhD, MPH1, (1)University of Oslo, Oslo, Norway, (2)Diakonhjemmet Hospital, Oslo, Norway
13
(ESP)
*
COST-EFFECTIVENESS OF MANUAL THERAPY, EXERCISE, AND MANUAL THERAPY AND EXERCISE COMBINED FOR THE MANAGEMENT OF OSTEOARTHRITIS OF THE HIP AND/OR KNEE
Daniel Pinto, DPT, M. Clare Robertson, BSc[Hons], BCom, PhD, Paul Hansen, BCom, PGDipCom, MEc, PhD and J. Haxby Abbott, DipPhty, DipGrad, MScPT, PhD, University of Otago, Dunedin, New Zealand
14
(ESP)
*
BLACK RACE IS ASSOCIATED WITH PREFERENTIAL USE OF HOSPICE AT HOME VERSUS AT A SKILLED NURSING FACILITY
Cyrena Torrey Simons, MD, PhD, VA Palo Alto Health Care System and Stanford University, Stanford, CA, Monica Bhargava, MD, Stanford University School of Medicine, Stanford, CA and Jayanta Bhattacharya, MD, PhD, Stanford University, Stanford, CA
15
(ESP)
*
MORE INTENSIVE COLORECTAL CANCER SCREENING FOR OBESE SMOKERS: THE IMPACT OF LIFE EXPECTANCY
Maaike A. Meulenberg, MSc1, Iris Lansdorp-Vogelaar, PhD1, Y. Claire Wang, MD, ScD2, Eric J. Feuer, PhD3, Ann G. Zauber, PhD4, Harry J. de Koning, MD, PhD1, Marjolein van Ballegooijen, MD, PhD1 and E.M. Wever, MSc5, (1)Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, (2)Mailman School of Public Health, New York, NY, (3)National Cancer Institute, Bethesda, MD, (4)Memorial Sloan-Kettering Cancer Center, New York, NY, (5)Erasmus Medical Center, Rotterdam, Netherlands
16
(ESP)
*
ANALYZING CLAIMS DATA FOR HEALTH SERVICES USE IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
Patrick Einzinger1, Günther Zauner2, Niki Popper2, Gottfried Endel3 and Felix Breitenecker1, (1)Vienna University of Technology, Vienna, Austria, (2)Dwh Simulation Services, Vienna, Austria, (3)Main Association of Austrian Social Security Institutions, Vienna, Austria
17
(ESP)
*
BLEEDING RISK AND ANTICOAGULATION DURATION AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: A DECISION ANALYSIS
Anna K. Donovan, M.D.1, Margaret V. Ragni, M.D., M.P.H.1 and Kenneth J. Smith, MD, MS2, (1)University of Pittsburgh School of Medicine, Pittsburgh, PA, (2)University of Pittsburgh, Pittsburgh, PA
18
(ESP)
*
RISK ANALYSIS AND DECISION MAKING IN NEUROSURGERY: BRAIN MAPPING STRUCTURAL INVARIANT OF COGNITIVE FUNCTIONS FOR SURGICAL PLANNING
Olena Nikolenko, M.D., Ph.D., Tufts Medical Center, Boston, MA, Lusiena Klaupik, M.D., Ph.D., Odessa National Medical University, Odessa, Ukraine and Oleg Nikolenko, PhD, Odessa National University, Odessa, Ukraine
19
(ESP)
*
ACCEPTABILITY OF TEXT MESSAGING AS A TOOL TO COMMUNICATE WITH CHRONIC LIVER DISEASE PATIENTS
Ayan Rage, MD1, Tuyyab Hassan, MD, MRCP1, Ayesha Kanwal, MD1, Kevin Mullen, MD1 and Adam T. Perzynski, PhD2, (1)Metrohealth Medical Center, Cleveland, OH, (2)Case Western Reserve University at MetroHealth, Cleveland, OH
21
(ESP)
*
SHOULD CELL FREE FETAL DNA TESTING REPLACE ANTENATAL RHESUS IMMUNE GLOBULIN ADMINISTRATION?
Kimberly K. Ma, MD1, Maria I. Rodriguez, MD, MPH1, Yvonne Cheng, MD, MPH2, Mary E. Norton, MD3 and Aaron B. Caughey, MD, MPP, MPH, PhD4, (1)Oregon Health and Science University, Portland, OR, (2)University of California, San Francisco, CA, (3)Stanford University, Stanford, CA, (4)Oregon Health & Sciences University, Portland, OR
22
(ESP)
*
CATHETER ABLATION STRATEGIES FOR RHYTHM CONTROL IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Nazila Assasi1, Feng Xie1, Gord Blackhouse1, Kathryn Gaebel2, Diana Robertson1, Robert Hopkins, MA1, Jeff S. Healey1 and Ron Goeree1, (1)McMaster University, Hamilton, ON, Canada, (2)St Josephs Healthcare, Hamilton, ON, Canada
23
(ESP)
*
CONSIDERATIONS FOR TARGETED RECRUITMENT OF PATIENTS WITH A CHRONIC CONDITION USING AN ONLINE SURVEY
Kristin M. Khalaf, PharmD1, Sonya Eremenco, MA2, Denise Globe, PhD1, Edward P. Armstrong, PharmD3, Daniel C. Malone, RPh, PhD3 and Karin Coyne, PhD, MPH2, (1)Allergan, Inc, Irvine, CA, (2)United BioSource Corporation, Bethesda, MD, (3)University of Arizona, Tucson, AZ
28
(BEC)
RANDOMIZED TRIAL OF PAIRED AND TRIPLET PROFILE CHOICE TASKS IN THE ELICITATION OF PATIENT PREFERENCES FOR HEARING AIDS WITH CONJOINT ANALYSIS
John F.P. Bridges, PhD1, Karin.G.M. Groothuis-Oudshoorn, PhD2 and Christine Buttorff, BA1, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)University of Twente, Enschede, Netherlands
31
(BEC)
PROJECTION BIAS AMONG PERSONS RECEIVING SPINAL INJECTION AS TREATMENT FOR LUMBAR PAIN
Richard Wilson, MD, MS, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, Justin Sydnor, PhD, University of Wisconsin, Madison, WI, Brian Snitily, Case Western Reserve University, Cleveland, OH and Adam T. Perzynski, PhD, Case Western Reserve University at MetroHealth, Cleveland, OH
34
(BEC)
ASSESSING THE INFLUENCE OF DELAY DISCOUNTING OF FUTURE HEALTH ON DIET AND PHYSICAL ACTIVITY BEHAVIORS: DOES IT DIFFER BY BODY MASS INDEX CATEGORY?
Kimberly Bosworth Blake, PharmD, MBA, PhD, Auburn University Harrison School of Pharmacy, Auburn, AL and Carole V. Harris, PhD, West Virginia University School of Medicine, Morgantown, WV
35
(BEC)
SHOULD PATIENTS WITH RESPIRATORY TRACT INFECTIONS REFRAIN FROM EXERCISE, STAY INDOORS OR STAY IN BED? SURVEY OF GENERAL PRACTITIONERS` JUDGEMENTS IN POLAND AND NORWAY
Peder A. Halvorsen, MD, PhD1, Maciek Godycki-Cwirko, MD, PhD2, Katrine Wennevold, MD1 and Hasse Melbye, MD, PhD1, (1)University of Tromsø, Tromsø, Norway, (2)Medical University of Lodz, Lodz, Poland
36
(ESP)
THE IMPACT OF PEER PRESSURE AND RISK PREFERENCE ON SMOKING, DRINKING AND DIETING BEHAVIOR AMONG JAPANESE ADOLESCENT AND COLLEGE STUDENT
Sachiko Shimizu, RN, MSC1, Megumi Hori, MSC1, Mai Utada, MSC1, Maya Iwasa, RN, PhD2, Rie Tomizawa, RN, MSC2 and Yuko Ohno, PhD1, (1)Osaka University, Suita, Osaka, Japan, (2)Senri-Kinran University, Suita, Osaka, Japan
37
(DEC)
*
FACTORS IN INFORMED DECISION MAKING IN HEPATITIS C TESTING
Anna M. Quinn, MPH, Candidate1, Heidi Swan, MPH1, Randa Sifri, MD1, Victor Nevarro, MD2, Ronald E. Myers, PhD1 and Amy Leader, DrPH, MPH1, (1)Thomas Jefferson University, Philadelphia, PA, (2)Jefferson Medical College, Philadelphia, PA
38
(DEC)
*
END-OF-LIFE DECISIONS IN THE HOSPITAL; WHAT DO PATIENTS PREFER?
Frederika E. Witkamp, RN1, L. van Zuylen, MD, PhD2, C.C.D. van der Rijt, MD, PhD, Prof2 and A. van der Heide, MD, PhD2, (1)Erasmus MC University Medical Center, Rotterdam, Netherlands, (2)Erasmus MC University Medical Centre, Rotterdam, Netherlands
42
(DEC)
*
HPV VACCINATION YES OR NO: A QUESTIONNAIRE STUDY AMONG PARENTS ON DETERMINANTS OF INTENTIONS
Robine Hofman, MSc1, Pepijn van Empelen, PhD2, Jan-Hendrik Richardus, MD, PhD3, Inge M.C.M. de Kok, PhD1, Marjolein van Ballegooijen, MD, PhD1 and Ida J. Korfage, PhD1, (1)Erasmus MC - University Medical Center, Rotterdam, Netherlands, (2)Erasmus MC - University Medical Center; TNO Quality of Life, Rotterdam, Netherlands, (3)Erasmus MC - University Medical Center; Municipal Public Health Service Rotterdam-Rijnmond, Rotterdam, Netherlands
43
(DEC)
*
HOW DO PATIENTS RESOLVE CONFLICTING MEDICATION RELATED INFORMATION?
Emily A. Elstad, MPH, Delesha M. Carpenter, PhD, MSPH, Robert F. DeVellis, PhD and Susan J. Blalock, PhD, MPH, University of North Carolina at Chapel Hill, Chapel Hill, NC
45
(DEC)
*
DEVELOPMENT OF A TOOL FOR IDENTIFICATION AND CLASSIFICATION OF DECISIONS IN MEDICAL ENCOUNTERS
Eirik H. Ofstad, MD1, Jan C. Frich, MD, PhD2, Edvin Schei, MD, PhD3, Arnstein Finset, Psy.D, PhD2 and Pål Gulbrandsen, MD, PhD1, (1)Akershus University Hospital, Lørenskog, Norway, (2)University of Oslo, Oslo, Norway, (3)University of Bergen, Bergen, Norway
46
(DEC)
RACIAL/ETHNIC VARIATION IN THE INVOLVEMENT OF PARTNERS IN BREAST CANCER TREATMENT DECISION MAKING
Sarah T. Hawley, PhD, MPH1, Nancy Janz, PhD2, Ann Hamilton, PhD3, Kendra Schwartz, MD, MPH4 and Steven Katz, MD1, (1)University of Michigan, Ann Arbor VA Health System, Ann Arbor, MI, (2)University of Michigan, School of Public Health, Ann Arbot, MI, (3)USC, Keck School of Medicine, Los Angeles, CA, (4)Wayne State University, Detroit, MI
47
(DEC)
USABILITY AND EFFICACY TESTING OF A SPANISH LANGUAGE COLORECTAL CANCER SCREENING DECISION AID IN LATINOS WITH LIMITED ENGLISH PROFICIENCY
Daniel S. Reuland, MD, MPH, University of North Carolina, Chapel Hill, NC, Linda K. Ko, PhD, MPH, University of North Carolina - Chapel Hill, Chapel Hill, NC and Michael Pignone, MD, MPH, University of North Carolina at Chapel Hill, Chapel Hill, NC
48
(DEC)
DEVELOPMENT AND PRELIMINARY EVALUATION OF EMERGENCY MEDICAL ALLIANCE FOR TOTAL COODINATION IN HEALTHCARE (E-MATCH) TO RESOLVE MISMATCH BETWEEN PATIENTS NEEDS AND AVAILABLE RESOURCES
Michi Sakai, PhD1, Sachiko Ohta, MD2, Satoko Zenitani, MPH1, Hidetada Fukushima, MD3, Fumio Takesue, MD4, Kazuo Okuchi, MD3, Akinobu Tachibana5, Eiji Higashi6 and Noriaki Aoki, MD7, (1)Center for Health Service, Outcomes Research and Development - Japan (CHORD-J), Tokyo, Japan, (2)Health Informatics and Management Professionals (HIMAP) General Association, Tokyo, Japan, (3)Nara Medical University, Nara, Japan, (4)Nara Prefecture Government, Nara, Japan, (5)Ikoma Fire Department, Nara, Japan, (6)Nara Fire Bureau, Nara, Japan, (7)University of Texas - Houston, Houston, TX
50
(MET)
*
EXPERT ELICITATION TO POPULATE EARLY HEALTH ECONOMIC MODELS OF MEDICAL DIAGNOSTIC DEVICES IN DEVELOPMENT
Wieke Haakma, BSc1, Laura Bojke, PhD, MSc, BA2, Lotte Steuten, PhD3 and Maarten J. IJzerman, PhD1, (1)University of Twente, Enschede, Netherlands, (2)University of York, York, United Kingdom, (3)University of Twente, AE Enschede, Netherlands
51
(MET)
THE VALUE OF MARKERS IN PREDICTION MODELS: NET BENEFIT AND TEST HARM RATHER THAN THE C-INDEX
Ben Van Calster, PhD, Katholieke Universiteit Leuven, Leuven, Belgium, Dirk Timmerman, University Hospitals Leuven, Leuven, Belgium and Ewout W. Steyerberg, PhD, Department of Public Health, AE 236, Rotterdam, Netherlands
52
(MET)
COMPARISON OF VARIABLE SELECTION METHODS FOR THE GENERATION OF PARSIMONIOUS PREDICTION MODELS FOR USE IN CLINICAL PRACTICE
Brian J. Wells, MD, MS1, Changhong Yu, MS1, Siran Koroukian, PhD2 and Michael W. Kattan, PhD1, (1)Cleveland Clinic, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH
53
(MET)
IMPROVING THE EFFICIENCY OF THE ANALYTIC HIERARCHY PROCESS
Christine M. Duffy, MD, MPH, Brown University, Providence, RI, Rahul Banerjee, BS, Brown Medical School, Providence, RI and James G. Dolan, MD, University of Rochester, Rochester, NY
54
(MET)
TRANSPLANT CENSORING AND THE NATURAL HISTORY OF MELD VIA EM ESTIMATION
Gordon B. Hazen, PhD, Northwestern University, Evanston, IL, Zhe Li, Northwestern Univ, Evanston, IL and Anton Skaro, M.D., Northwestern University, Feinberg School of Medicine, Chicago, IL
56
(MET)
COMPARATIVE EFFECTIVENESS RESEARCH TO AID DECISION MAKING: RELATING CLINICAL OUTCOMES AND QUALITY ADJUSTED LIFE YEARS
Jonathan D. Campbell, PhD, University of Colorado School of Pharmacy, Aurora, CO, Louis P. Garrison, Ph.D, University of Washington, Seattle, WA, Judy Zerzan, MD, MPH, Colorado Department of Health Care Policy and Financing, Denver, CO and Anne Libby, PhD, University of Colorado, Aurora, CO
